Literature DB >> 30205139

Epigenetic modulation of metabolism in glioblastoma.

Zhen Dong1, Hongjuan Cui2.   

Abstract

Epigenetic and metabolic alterations incancer cells are highly associated. Glioblastoma multiforme (GBM) is a complicated pathological process with dysregulated methylation and histone modifications. Metabolic modulation of epigenetics in gliomas was previously summarized. However, epigenetic modulation is also important in metabolic decision. Recently, there has been a tremendous increase in understanding of DNA methylation, chromatin modulation, and non-coding RNAs in the regulation of cell metabolism, especially glycolytic metabolism in GBM. In this review, we summarize DNA methylation, histone alteration, and non-coding RNA mediated epigenetic modulation of metabolism in GBM and discuss the future research directions in this area and its applications in GBM treatment.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cell metabolism; DNA methylation; Epigenetics; Glioblastoma; MicroRNA

Mesh:

Substances:

Year:  2018        PMID: 30205139     DOI: 10.1016/j.semcancer.2018.09.002

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  24 in total

Review 1.  Metabolic heterogeneity and adaptability in brain tumors.

Authors:  Christian E Badr; Daniel J Silver; Florian A Siebzehnrubl; Loic P Deleyrolle
Journal:  Cell Mol Life Sci       Date:  2020-06-06       Impact factor: 9.261

2.  m6A Regulatory Gene-Mediated Methylation Modification in Glioma Survival Prediction.

Authors:  Guiyun Zhang; Ping Zheng; Yisong Lv; Zhonghua Shi; Fei Shi
Journal:  Front Genet       Date:  2022-04-26       Impact factor: 4.772

Review 3.  Advances in Targeting the Epidermal Growth Factor Receptor Pathway by Synthetic Products and Its Regulation by Epigenetic Modulators As a Therapy for Glioblastoma.

Authors:  Muhammad Nadeem Abbas; Saima Kausar; Feng Wang; Yongju Zhao; Hongjuan Cui
Journal:  Cells       Date:  2019-04-12       Impact factor: 6.600

Review 4.  Epigenetic Regulation of p21cip1/waf1 in Human Cancer.

Authors:  Matthias Ocker; Samar Al Bitar; Ana Carolina Monteiro; Hala Gali-Muhtasib; Regine Schneider-Stock
Journal:  Cancers (Basel)       Date:  2019-09-11       Impact factor: 6.639

Review 5.  Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression.

Authors:  Fabiana Crispo; Valentina Condelli; Silvia Lepore; Tiziana Notarangelo; Alessandro Sgambato; Franca Esposito; Francesca Maddalena; Matteo Landriscina
Journal:  Cells       Date:  2019-07-30       Impact factor: 6.600

Review 6.  HSP90 Molecular Chaperones, Metabolic Rewiring, and Epigenetics: Impact on Tumor Progression and Perspective for Anticancer Therapy.

Authors:  Valentina Condelli; Fabiana Crispo; Michele Pietrafesa; Giacomo Lettini; Danilo Swann Matassa; Franca Esposito; Matteo Landriscina; Francesca Maddalena
Journal:  Cells       Date:  2019-06-03       Impact factor: 6.600

7.  CircMRPS35 suppresses gastric cancer progression via recruiting KAT7 to govern histone modification.

Authors:  Mengmeng Jie; Yaran Wu; Mengyuan Gao; Xinzhe Li; Cheng Liu; Qin Ouyang; Qingyun Tang; Changyu Shan; Yangfan Lv; Kebin Zhang; Qian Dai; Yang Chen; Shuo Zeng; Chenglin Li; Liting Wang; Fengtian He; Changjiang Hu; Shiming Yang
Journal:  Mol Cancer       Date:  2020-03-12       Impact factor: 27.401

8.  MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells.

Authors:  Zhen Dong; Jiahua Zou; Jifu Li; Yi Pang; Yudong Liu; Chaowei Deng; Fei Chen; Hongjuan Cui
Journal:  Cancer Med       Date:  2019-11-05       Impact factor: 4.452

9.  Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer.

Authors:  Liqun Yang; Qian Lei; Lin Li; Jie Yang; Zhen Dong; Hongjuan Cui
Journal:  Clin Epigenetics       Date:  2019-12-30       Impact factor: 6.551

Review 10.  Genotoxic therapy and resistance mechanism in gliomas.

Authors:  Fengchao Lang; Yang Liu; Fu-Ju Chou; Chunzhang Yang
Journal:  Pharmacol Ther       Date:  2021-06-23       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.